PMGC Holdings Inc. 8-K

What Happened
PMGC Holdings Inc. (ticker: ELAB) filed a Form 8-K on April 28, 2026 reporting a Regulation FD disclosure: its wholly owned Delaware subsidiary, NorthStrive Biosciences Inc., issued a press release that same day. The press release is furnished as Exhibit 99.1 to the 8-K.

Key Details

• Filing date: April 28, 2026 (Current Report on Form 8-K).
• Subsidiary: NorthStrive Biosciences Inc., a Delaware corporation and wholly owned by PMGC Holdings.
• Item reported: 7.01 (Regulation FD Disclosure); press release furnished as Exhibit 99.1.
• Exhibits listed under Item 9.01 include Exhibit 99.1 (press release) and the Inline XBRL cover page.

Why It Matters
A Regulation FD disclosure means the company made information public through a press release to ensure fair disclosure to all investors. The 8-K itself does not summarize the press release content; investors should review Exhibit 99.1 to see any operational, clinical, financial, or strategic details that could affect PMGC’s outlook. This filing does not by itself indicate earnings, executive changes, mergers, or other material events beyond the announced press release.